RecruitingNot ApplicableNCT06501560

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia


Sponsor

Dr.dr.Irma Bernadette, SpKK (K)

Enrollment

24 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Summary

This study is a series of descriptive-analytic studies on genomic variants in the facial skin of patients with AV at the Dermatology and Venereology Polyclinic by determining the genetic profile by GWAS examination in AVB and analysing the genetic profile in AVB against differences in geographical location. The research design used was a cross-sectional design.


Eligibility

Min Age: 17 YearsMax Age: 60 Years

Inclusion Criteria3

  • Males or females with AVB aged 17-21 years
  • Both parents of complete subjects with or without a history of acne vulgaris aged up to 60 years
  • Patients and parents are willing to participate in the study and sign informed consent.

Exclusion Criteria4

  • Patients who have other inflammatory or infectious diseases especially on the face
  • Have genetic diseases or disorders
  • Diagnosed with primary or secondary immunodeficiency diseases
  • Using oral or systemic antibiotic, anti-inflammatory, retinoid or hormone therapy in the past month.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICGWAS

In GWAS studies, data are collected to determine common variants in a number of individuals, either with or without a common trait (for example,. disease) across the genome, using genome wide SNP arrays.


Locations(1)

Universitas Indonesia

Jakarta Pusat, Jakarta Special Capital Region, Indonesia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06501560